Biocryst Pharmaceuticals (BCRX) Enterprise Value (QoQ) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47.89% |
| Mar 31, 2026 | 63.47% |
| Dec 31, 2025 | 12.99% |
| Sep 30, 2025 | -23.41% |
| Jun 30, 2025 | 9.30% |
| Mar 31, 2025 | 40.72% |
| Dec 31, 2024 | 2.78% |
| Sep 30, 2024 | -68.88% |
| Jun 30, 2024 | 41.94% |
| Mar 31, 2024 | 13.48% |
| Dec 31, 2023 | -56.68% |
| Sep 30, 2023 | 39.55% |
| Jun 30, 2023 | -67.97% |
| Mar 31, 2023 | -102.03% |
| Dec 31, 2022 | 71.65% |
| Sep 30, 2022 | -2.25% |
| Jun 30, 2022 | 5.86% |
| Mar 31, 2022 | 12.63% |
| Dec 31, 2021 | -154.31% |
| Sep 30, 2021 | 8.62% |